Loading...
•
Mar 31, 2021
Humana Q1 2021 Earnings Report
Humana's financial performance was solid in Q1 2021, driven by strong membership growth and improved profitability.
Key Takeaways
Humana reported a strong start to the year with solid results across the company's segments, fueled by Medicare Advantage and state-based membership growth. The company reaffirms its full-year adjusted EPS financial guidance.
Reported Q1 2021 GAAP earnings per diluted common share of $6.39 and adjusted earnings per diluted common share of $7.67.
Reaffirmed the full-year 2021 adjusted EPS guidance of $21.25 to $21.75, while acknowledging continued uncertainty surrounding the pandemic.
Reaffirmed the full-year 2021 expected individual Medicare Advantage membership growth range of approximately 425,000 to 475,000 members.
Saw solid performance across all company segments driven by strong individual Medicare Advantage and state-based membership growth, plus improved profitability in the Group and Specialty and Healthcare Services segments.
Revenue by Segment
Forward Guidance
Humana is revising its GAAP EPS guidance range for the year ending December 31, 2021 (FY 2021) to $19.62 to $20.12 from the previous range of $20.82 to $21.32, reflecting the 1Q21 impact of the company's non-consolidating minority interest put/call valuation adjustments and the change in the fair market value of publicly-traded equity securities held by the company. While continuing to acknowledge the heightened uncertainty surrounding the ongoing pandemic, Humana is maintaining its FY 2021 Adjusted EPS guidance range of $21.25 to $21.75.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...